Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

Metabolism

Volumn 35, Issue 3, 1986, Pages 250-253

  Vague, Philippe ^a,b,c   Juhan Vague, Irène ^a,b,c   Aillaud, Marie Francoise ^a,b,c   Badier, Christian ^a,b,c   Viard, Robert ^a,b,c   Alessi, Marie Christine ^a,b,c   Collen, Désiré ^a,b,c  

^a Service de Médecine Interne Nutrition Hôpital Universitaire Michel Levy ^*  (France)

^b TIMONE HOSPITAL   (France)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR;

BLOOD AND HEMOPOIETIC SYSTEM; FIBRINOLYSIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BODY WEIGHT; FEMALE; FIBRINOLYSIS; GLYCOPROTEINS; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; PLASMINOGEN INACTIVATORS; SERUM GLOBULINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0022625882     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(86)90209-X     Document Type: Article

References (29)

1. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
2. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions
3. Demonstration of a fast acting inhibitor of plasminogen activators in human plasma
4. Fibrinolysis, blood clotting, serum lipids, and body build of natives of New Guinea and Australians
5. Relationship between blood fibrinolytic activity and body fatness
6. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischémic heart disease and obesity
7. Fibrinolysis in obesity
8. Fibrinolysis and body build. Interrelationships between blood fibrinolysis, body composition, and parameters of lipid and carbohydrate metabolism
9. Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity
10. Low fibrinolytic activity in obesity
11. Plasma insulin and growth hormone levels in obesity and diabetes
12. Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetes
13. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
14. Screening of fibrinolytic activity in plasma euglobulin fraction on the fibrin plate
15. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay
16. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture
17. Fibrinolytic activity and treatment of diabetes
18. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile onset and maturity onset diabetes mellitus
19. Endothelial factors, toe temperature, and leg circulation in diabetics with and without autonomic neuropathy
20. Reduction of blood fibrinolytic activity in diabetes mellitus by insulin
21. Insulin and blood fibrinolytic activity
22. Influence of chlorpropamide and glucose on fibrinolytic activity
23. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis
24. Fibrinolytic activity related to age in survivors of myocardial infarction
25. Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease
26. Altered endogenous fibrinolysis and biochemical factors in atherosclerosis
27. Abnormalities in clotting and thrombolysis as a risk factor for stroke
28. Thrombosis as a factor in the pathogenesis of aortic atherosclerosis
29. Diabetes and atherosclerosis. The role of insulin